Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

BACKGROUND: Migraine is one of the leading causes of disability worldwide. Erenumab is a fully human monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. This study aimed to evaluate real-world evidence on the impact of erenumab on acute medication usage and health c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Fang, Juanzhi, Vo, Pamela, Shen, Ying, Zhou, Lujia, Abdrabboh, Ahmad, Glassberg, Mrudula, Ferraris, Matias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054394/
https://www.ncbi.nlm.nih.gov/pubmed/33874884
http://dx.doi.org/10.1186/s10194-021-01238-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054394/
https://www.ncbi.nlm.nih.gov/pubmed/33874884
http://dx.doi.org/10.1186/s10194-021-01238-2

Ejemplares similares